Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome
The five-year survival rate of lung cancer patients is very low, mainly because most newly diagnosed patients present with locally advanced or metastatic disease. Therefore, early diagnosis is key to the successful treatment and management of lung cancer. Unfortunately, early detection methods of lu...
Main Authors: | Jean-François Haince, Philippe Joubert, Horacio Bach, Rashid Ahmed Bux, Paramjit S. Tappia, Bram Ramjiawan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/3/1215 |
Similar Items
-
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study
by: Sandeep Singhal, et al.
Published: (2019-07-01) -
A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection
by: Lun Zhang, et al.
Published: (2020-03-01) -
Metabolomic Analyses to Identify Candidate Biomarkers of Cystinosis
by: Emirhan Nemutlu, et al.
Published: (2023-01-01) -
Untargeted Metabolomic Characterization of Ovarian Tumors
by: Xiaona Liu, et al.
Published: (2020-12-01) -
Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer
by: Qinsi Yang, et al.
Published: (2023-05-01)